Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism

Endocrinology

Volumn 145, Issue 11, 2004, Pages 5202-5209

  Smith, Sean M ^a   Vaughan, Joan M ^a   Donaldson, Cynthia J ^a   Rivier, Jean ^a   Li, Chien ^a   Chen, Alon ^a   Vale, Wylie W ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; ASTRESSIN; ASTRESSIN B; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE[55-102]; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; MESSENGER RNA; UNCLASSIFIED DRUG;

ADENOHYPOPHYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; DRUG ADMINISTRATION ROUTE; DRUG MECHANISM; DRUG RECEPTOR BINDING; EXPLANT; GENE EXPRESSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRESS;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ARGININE VASOPRESSIN; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; GENE EXPRESSION; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; PITUITARY GLAND, ANTERIOR; PITUITARY-ADRENAL SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; SECOND MESSENGER SYSTEMS;

EID: 9244246773     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-0708     Document Type: Article

References (51)

1. Douglass J, McKinzie AA, Couceyro P 1995 PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J Neurosci 15:2471-2481
2. Adams LD, Gong W, Vechia SD, Hunter RG, Kuhar MJ 1999 CART: from gene to function. Brain Res 848:137-140
3. Kuhar MJ, Adams S, Dominguez G, Jaworski J, Balkan B 2002 CART peptides. Neuropeptides 36:1-8
4. Thim L, Kristensen P, Larsen PJ, Wulff BS 1998 CART, a new anorectic peptide. Int J Biochem Cell Biol 30:1281-1284
5. Thim L, Kristensen P, Nielsen PF, Wulff BS, Clausen JT 1999 Tissue-specific processing of cocaine- and amphetamine-regulated transcript peptides in the rat. Proc Natl Acad Sci USA 96:2722-2727
6. Kuhar MJ, Dall Vechia SE 1999 CART peptides: novel addiction-and feeding-related neuropeptides. Trends Neurosci 22:316-320
7. Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, Clausen JT, Jensen PB, Madsen OD, Vrang N, Larsen PJ, Hastrup S 1998 Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393:72-76
8. Lambert PD, Couceyro PR, McGirr KM, Dall Vechia SE, Smith Y, Kuhar MJ 1998 CART peptides in the central control of feeding and interactions with neuropeptide Y. Synapse 29:293-298
9. Thim L, Nielsen PF, Judge ME, Andersen AS, Diers I, Egel-Mitani M, Hastrup S 1998 Purification and characterisation of a new hypothalamic satiety peptide, cocaine and amphetamine regulated transcript (CART), produced in yeast. FEBS Lett 428:263-268
10. Kuhar MJ, Adams LD, Hunter RG, Vechia SD, Smith Y 2000 CART peptides. Regul Pept 89:1-6
11. Wierup N, Kuhar M, Nilsson BO, Mulder H, Ekblad E, Sundler F 2004 Cocaine- and amphetamine-regulated transcript (CART) is expressed in several islet cell types during rat development. J Histochem Cytochem 52:169-177
12. Gautvik KM, de Lecea L, Gautvik VT, Danielson PE, Tranque P, Dopazo A, Bloom FE, Sutcliffe JG 1996 Overview of the most prevalent hypothalamus-specific mRNAs, as identified by directional tag PCR subtraction. Proc Natl Acad Sci USA 93:8733-8738
13. Elias CF, Lee CE, Kelly JF, Ahima RS, Kuhar M, Saper CB, Elmquist JK 2001 Characterization of CART neurons in the rat and human hypothalamus. J Comp Neurol 432:1-19
14. Koylu EO, Couceyro PR, Lambert PD, Ling NC, DeSouza EB, Kuhar MJ 1997 Immunohistochemical localization of novel CART peptides in rat hypothalamus, pituitary and adrenal gland. J Neuroendocrinol 9:823-833
15. Vrang N, Larsen PJ, Clausen JT, Kristensen P 1999 Neurochemical characterization of hypothalamic cocaine-amphetamine-regulated transcript neurons. J Neurosci 19:RC5
16. Vale W, Spiess J, Rivier C, Rivier J 1981 Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213:1394-1397
17. Koylu EO, Couceyro PR, Lambert PD, Kuhar MJ 1998 Cocaine- and amphetamine-regulated transcript peptide immunohistochemical localization in the rat brain. J Comp Neurol 391:115-132
18. Stanley SA, Small CJ, Murphy KG, Rayes E, Abbott CR, Seal LJ, Morgan DG, Sunter D, Dakin CL, Kim MS, Hunter R, Kuhar M, Ghatei MA, Bloom SR 2001 Actions of cocaine- and amphetamine-regulated transcript (CART) peptide on regulation of appetite and hypothalamo-pituitary axes in vitro and in vivo in male rats. Brain Res 893:186-194
19. Chaki S, Kawashima N, Suzuki Y, Shimazaki T, Okuyama S 2003 Cocaine- and amphetamine-regulated transcript peptide produces anxiety-like behavior in rodents. Eur J Pharmacol 464:49-54
20. Kuriyama G, Takekoshi S, Tojo K, Nakai Y, Kuhar MJ, Osamura RY 2004 CART peptide in the rat anterior pituitary gland is localized in gonadotrophs and suppresses prolactin secretion. Endocrinology 145:2542-2550
21. Larsen PJ, Seier V, Fink-Jensen A, Holst JJ, Warberg J, Vrang N 2003 Cocaine- and amphetamine-regulated transcript is present in hypothalamic neuroendocrine neurones and is released to the hypothalamic-pituitary portal circuit. J Neuroendocrinol 15:219-226
22. Fekete C, Mihaly E, Luo LG, Kelly J, Clausen JT, Mao Q, Rand WM, Moss LG, Kuhar M, Emerson CH, Jackson IM, Lechan RM 2000 Association of cocaine- and amphetamine-regulated transcript-immunoreactive elements with thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and its role in the regulation of the hypothalamic-pituitary-thyroid axis during fasting. J Neurosci 20:9224-9234
23. Turnbull AV, Rivier C 1996 Corticotropin-releasing factor, vasopressin, and prostaglandins mediate, and nitric oxide restrains, the hypothalamic- piruitary-adrenal response to acute local inflammation in the rat. Endocrinology 137: 455-463
24. Rivier J, Gulyas J, Kirby D, Low W, Perrin MH, Kunitake K, DiGruccio M, Vaughan J, Reubi JC, Waser B, Koerber SC, Martinez V, Wang L, Tache Y, Vale W 2002 Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists. J Med Chem 45: 4737-4747
25. Gulyas J, Rivier C, Perrin M, Koerber SC, Button S, Corrigan A, Lahrichi SL, Craig AG, Vale W, Rivier J 1995 Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor. Proc Natl Acad Sci USA 92:10575-10579
26. Kimmel HL, Thim L, Kuhar MJ 2002 Activity of various CART peptides in changing locomotor activity in the rat. Neuropeptides 36:9-12
27. Vrang N, Larsen PJ, Kristensen P, Tang-Christensen M 2000 Central administration of cocaine-amphetamine-regulated transcript activates hypothalamic neuroendocrine neurons in the rat. Endocrinology 141:794-801
28. Yermolaieva O, Chen J, Couceyro PR, Hoshi T 2001 Cocaine- and amphetamine-regulated transcript peptide modulation of voltage-gated Ca2+ signaling in hippocampal neurons. J Neurosci 21:7474-7480
29. Vale W, Vaughan J, Yamamoto G, Bruhn T, Douglas C, Dalton D, Rivier C, Rivier J 1983 Assay of corticotropin releasing factor. Methods Enzymol 103: 565-577
30. Rivier C, Shen GH 1994 In the rat, endogenous nitric oxide modulates the response of the hypothalamic-pituitary-adrenal axis to interleukin-1β, vasopressin, and oxytocin. J Neurosci 14:1985-1993
31. Wagner M, Perry RP 1985 Characterization of the multigene family encoding the mouse S16 ribosomal protein: strategy for distinguishing an expressed gene from its processed pseudogene counterparts by an analysis of total genomic DNA. Mol Cell Biol 5:3560-3576
32. Rivier J, Gulyas J, Corrigan A, Martinez V, Craig AG, Tache Y, Vale W, Rivier C 1998 Astressin analogues (corticotropin-releasing factor antagonists) with extended duration of action in the rat. J Med Chem 41:5012-5019
33. Sarkar S, Wittmann G, Fekete C, Lechan RM 2004 Central administration of cocaine- and amphetamine-regulated transcript increases phosphorylation of cAMP response element binding protein in corticotropin-releasing hormone-producing neurons but not in prothyrotropin-releasing hormone-producing neurons in the hypothalamic paraventricular nucleus. Brain Res 999:181-192
34. Rivier CL, Grigoriadis DE, Rivier JE 2003 Role of corticotropin-releasing factor receptors type 1 and 2 in modulating the rat adrenocorticotropin response to stressors. Endocrinology 144:2396-2403
35. Vrang N, Tang-Christensen M, Larsen PJ, Kristensen P 1999 Recombinant CART peptide induces c-Fos expression in central areas involved in control of feeding behaviour. Brain Res 818:499-509
36. Rivier C, Vale W 1983 Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo. Endocrinology 113: 939-942
37. Vale W, Vaughan J, Smith M, Yamamoto G, Rivier J, Rivier C 1983 Effects of synthetic ovine corticotropin-releasing factor, glucocorticoids, catecholamines, neurohypophysial peptides, and other substances on cultured corticotropic cells. Endocrinology 113:1121-1131
38. Sawchenko PE, Swanson LW 1985 Localization, colocalization, and plasticity of corticotropin-releasing factor immunoreactivity in rat brain. Fed Proc 44: 221-227
39. Sawchenko PE, Imaki T, Potter E, Kovacs K, Imaki J, Vale W 1993 The functional neuroanatomy of corticotropin-releasing factor. Ciba Found Symp 172:5-21; discussion 21-29
40. Widmaier EP, Lim AT, Vale W 1989 Secretion of corticotropin-releasing factor from cultured rat hypothalamic cells: effects of catecholamines. Endocrinology 124:583-590
41. al-Damluji S 1988 Adrenergic mechanisms in the control of corticotrophin secretion. J Endocrinol 119:5-14
42. Whitnall MH 1993 Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Prog Neurobiol 40:573-629
43. Petrov T, Krukoff TL, Jhamandas JH 1994 Chemically defined collateral projections from the pons to the central nucleus of the amygdala and hypothalamic paraventricular nucleus in the rat. Cell Tissue Res 277:289-295
44. Bagdy G 1996 Role of the hypothalamic paraventricular nucleus in 5-HT1A, 5-HT2A and 5-HT2C receptor-mediated oxytocin, prolactin and ACTH/ corticosterone responses. Behav Brain Res 73:277-280
45. Van de Kar LD, Javed A, Zhang Y, Serres F, Raap DK, Gray TS 2001 5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells. J Neurosci 21:3572-3579
46. Leonard JF, Bluet-Pajot MT, Oliver C, Kordon C 1988 Interaction of vasoactive intestinal peptide (VIP) and growth hormone releasing factor (GRF) with corticotropin releasing factor (CRF) on corticotropin secretion in vitro. Neuropeptides 12:131-133
47. Westendorf JM, Schonbrunn A 1985 Peptide specificity for stimulation of corticotropin secretion: activation of overlapping pathways by the vasoactive intestinal peptide family and corticotropin-releasing factor. Endocrinology 116:2528-2535
48. Malendowicz LK, Lesniewska B, Miskowiak B 1990 Neuropeptide Y inhibits corticosterone secretion by isolated rat adrenocortical cells. Experientia 46: 721-722
49. Thorsell A, Michalkiewicz M, Dumont Y, Quirion R, Caberlotto L, Rimondini R, Mathe AA, Heilig M 2000 Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc Natl Acad Sci USA 97:12852-12857
50. Tsutsumi T, Akiyoshi J, Hikichi T, Kiyota A, Kohno Y, Katsuragi S, Yamamoto Y, Isogawa K, Nagayama H 2001 Suppression of conditioned fear by administration of CCKB receptor antisense oligodeoxynucleotide into the lateral ventricle. Pharmacopsychiatry 34:232-237
51. Tsutsumi T, Akiyoshi J, Isogawa K, Kohno Y, Hikichi T, Nagayama H 1999 Suppression of conditioned fear by administration of CCKB receptor antagonist PD135158. Neuropeptides 33:483-486